Myeong-Kyu Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Myeong-Kyu Kim has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
Tai-Seung Nam
Department of Neurology, Chonnam National University Medical School, Gwangju, 61469, South Korea
17 shared publications- Seok-Yong Choi
Department of Biomedical Sciences, Chonnam National University Medical School, Hwasun 58128, Republic of Korea
16 shared publications Ki-Hyun Cho
Department of Neurology, The Brain Korea 21 Project, Center for Biomedical Human Resources, Chonnam National University Medical School, Gwangju, Korea
7 shared publications- Kyung Wook Kang
Department of Neurology, Chonnam National University Medical School and Chonnam National University Hospital, Gwangju, Korea
7 shared publications Byeong-Chae Kim
6 shared publicationsMan-Seok Park
Department of Neurology, Chonnam National University Medical School, Gwangju, 61469, South Korea
5 shared publications
Latest Publications
- Open Access
- 1 June 2025
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 18 (6)
Mutant zebrafish lacking slc25a22a show spontaneous seizures and respond to the anti-seizure medication valproic acid
Epilepsy is a neurological disorder associated with abnormal neuronal activity in the central nervous system, resulting in recurrent seizures. Various anti-seizure medications (ASMs) are effective against epilepsy. However, approximately one-third of patients still do not respond to currently available ASMs either alone or in combination because the etiology of their epilepsy remains unclear. To create a novel zebrafish epilepsy model, we analyzed the exomes of 400 Korean patients with epilepsy via whole-exome sequencing. We found 39 candidate genes and investigated these genes through in situ hybridization and loss-of-function studies, identifying SLC25A22, encoding a mitochondrial glutamate carrier, as a potential epilepsy gene. Subsequently, we generated zebrafish slc25a22a mutants and observed that they displayed spontaneous seizures, high-voltage deflections in local field potentials, and elevated Ca2+ levels propagating from the forebrain to the spinal cord. Of nine ASMs tested, valproic acid (VPA) was able to suppress spontaneous seizure activities in slc25a22a mutant larvae, highlighting the unique anti-seizure effect of VPA in this model. Our findings provide valuable insights into the pathogenesis of epilepsy and suggest slc25a22a as a potential target for novel ASM development.
- 1 June 2025
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 18 (6)
Open AccessMutant zebrafish lacking slc25a22a show spontaneous seizures and respond to the anti-seizure medication valproic acid
Epilepsy is a neurological disorder associated with abnormal neuronal activity in the central nervous system, resulting in recurrent seizures. Various anti-seizure medications (ASMs) are effective against epilepsy. However, approximately one-third of patients still do not respond to currently available ASMs either alone or in combination because the etiology of their epilepsy remains unclear. To create a novel zebrafish epilepsy model, we analyzed the exomes of 400 Korean patients with epilepsy via whole-exome sequencing. We found 39 candidate genes and investigated these genes through in situ hybridization and loss-of-function studies, identifying SLC25A22, encoding a mitochondrial glutamate carrier, as a potential epilepsy gene. Subsequently, we generated zebrafish slc25a22a mutants and observed that they displayed spontaneous seizures, high-voltage deflections in local field potentials, and elevated Ca2+ levels propagating from the forebrain to the spinal cord. Of nine ASMs tested, valproic acid (VPA) was able to suppress spontaneous seizure activities in slc25a22a mutant larvae, highlighting the unique anti-seizure effect of VPA in this model. Our findings provide valuable insights into the pathogenesis of epilepsy and suggest slc25a22a as a potential target for novel ASM development.
- 9 February 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 126, 79-85
Yield in routine electroencephalography in adults with newly diagnosed epilepsy at a third-level epilepsy center in South Korea
- 9 February 2025
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 126, 79-85
Yield in routine electroencephalography in adults with newly diagnosed epilepsy at a third-level epilepsy center in South Korea
- Open Access
- 1 April 2024
- Published by Korean Sleep Society in Journal of Sleep Medicine
- Vol. 21 (1) , 20-27
Expert Survey on Managing Safety Events in Sleep Laboratory
Objectives: An increasing number of studies have highlighted the impact of sleep on physical and mental health and a corresponding rise in public interest; numbers of polysomnography (PSG) examinations have correspondingly increased. However, research and recommendations concerning safety events that may occur during PSG are lacking. This study aimed to investigate the current status of safety events in sleep laboratories in Korea and gather expert opinions on this matter. Methods: We conducted a web-based survey of Korean sleep experts to explore their opinions on safety events in sleep laboratories. Results: All Korean sleep experts who participated in this study agreed on the need for guidelines concerning safety events that can occur during PSG. Through this survey, they provided insights into the cardiac and pulmonary safety events that may arise during PSG. Conclusions: This study can assist sleep physicians in managing safety events in sleep laboratories currently, and in the future, it may contribute to the development of guidelines for handling safety events during PSG.
- 1 April 2024
- Published by Korean Sleep Society in Journal of Sleep Medicine
- Vol. 21 (1) , 20-27
Open AccessExpert Survey on Managing Safety Events in Sleep Laboratory
Objectives: An increasing number of studies have highlighted the impact of sleep on physical and mental health and a corresponding rise in public interest; numbers of polysomnography (PSG) examinations have correspondingly increased. However, research and recommendations concerning safety events that may occur during PSG are lacking. This study aimed to investigate the current status of safety events in sleep laboratories in Korea and gather expert opinions on this matter. Methods: We conducted a web-based survey of Korean sleep experts to explore their opinions on safety events in sleep laboratories. Results: All Korean sleep experts who participated in this study agreed on the need for guidelines concerning safety events that can occur during PSG. Through this survey, they provided insights into the cardiac and pulmonary safety events that may arise during PSG. Conclusions: This study can assist sleep physicians in managing safety events in sleep laboratories currently, and in the future, it may contribute to the development of guidelines for handling safety events during PSG.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (49) , e413
Association Between Electronic Device Use at Bedtime and COVID-19 Vaccine-Related Adverse Events During the COVID-19 Pandemic in Korean Adults: A Nationwide Cross-Sectional Population-Based Study
Kang KW, et al. J Korean Med Sci. 2023 Dec;38:e413. https://doi.org/10.3346/jkms.2023.38.e413
- 1 January 2023
- Published by XMLink in Journal of Korean Medical Science
- Vol. 38 (49) , e413
Open AccessAssociation Between Electronic Device Use at Bedtime and COVID-19 Vaccine-Related Adverse Events During the COVID-19 Pandemic in Korean Adults: A Nationwide Cross-Sectional Population-Based Study
Kang KW, et al. J Korean Med Sci. 2023 Dec;38:e413. https://doi.org/10.3346/jkms.2023.38.e413
- Open Access
- 30 September 2022
- Published by Korean Clinical Epilepsy Research Society in Epilia: Epilepsy and Community
- Vol. 4 (2) , 68-72
Decitabine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Myelodysplastic Syndrome
- 30 September 2022
- Published by Korean Clinical Epilepsy Research Society in Epilia: Epilepsy and Community
- Vol. 4 (2) , 68-72
Open AccessDecitabine-Induced Posterior Reversible Encephalopathy Syndrome in a Patient with Myelodysplastic Syndrome
- Open Access
- 23 September 2022
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 18 (6) , 717-719
Electroclinical Characteristics and 18F-Fluorodeoxyglucose Positron-Emission Tomography Findings of Familial Scotosensitivity
Kang KW, et al. J Clin Neurol. 2022 Nov;18(6):717-719. https://doi.org/10.3988/jcn.2022.18.6.717
- 23 September 2022
- Published by Korean Neurological Association in Journal of Clinical Neurology
- Vol. 18 (6) , 717-719
Open AccessElectroclinical Characteristics and 18F-Fluorodeoxyglucose Positron-Emission Tomography Findings of Familial Scotosensitivity
Kang KW, et al. J Clin Neurol. 2022 Nov;18(6):717-719. https://doi.org/10.3988/jcn.2022.18.6.717
- Open Access
- 24 August 2022
- Published by XMLink in Journal of Clinical Neurology
- Vol. 18 (5) , 553-561
Multidimensional Early Prediction Score for Drug-Resistant Epilepsy
Kang KW, et al. J Clin Neurol. 2022 Sep;18(5):553-561. https://doi.org/10.3988/jcn.2022.18.5.553
- 24 August 2022
- Published by XMLink in Journal of Clinical Neurology
- Vol. 18 (5) , 553-561
Open AccessMultidimensional Early Prediction Score for Drug-Resistant Epilepsy
Kang KW, et al. J Clin Neurol. 2022 Sep;18(5):553-561. https://doi.org/10.3988/jcn.2022.18.5.553
- Open Access
- 27 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3703
A Genotype-Phenotype Study of Multiple Hereditary Exostoses in Forty-Three Patients
Multiple hereditary exostoses (MHE) is a rare autosomal dominant skeletal disorder with a variety of clinical manifestations. We aimed to evaluate the general clinical phenotypic severity of MHE using our own scoring system and analyzed the risk factors associated with severe clinical phenotypes. In this study, 43 patients from 30 families were analyzed. The mutations were identified by direct sequencing of polymerase chain reaction-amplified genomic DNA or by multiplex ligation-dependent probe amplification. According to a new scoring system devised by the authors, the severity of the phenotype was assessed as mild, moderate, or severe based on the deformity of each segment, number of exostoses, leg length discrepancy, and functional limitations. Of 43 patients from 30 families, 39 patients (90.7%) and 24 families (80%) presented with EXT1 or EXT2 mutations. Patients with EXT1 mutations had a significantly worse phenotype than that of patients with EXT2 mutations or without any detectable mutation. The mean clinical score of patients with an EXT1 mutation (5.76; range, 2.0–8.0; SD = 1.60) was higher than that of patients with an EXT2 mutation (4.06; range, 2.0–7.0; SD = 1.47) or of those without any detectable mutation (4.63; range, 3.0–6.0; SD = 1.44; p = 0.005). According to our classification system, more patients with EXT1 mutations had ‘severe disease’ than those with EXT2 mutations. Deformity scores were also higher in patients with EXT1 mutations (p = 0.018). In the multivariate analysis, the deformity score was found to be associated with the ‘severe’ class (p = 0.031). In conclusion, 90.7% of patients with MHE showed EXT mutations. Our scoring system showed reliable results. We suggest that the extent of deformity is an important factor in determining the phenotype of MHE and close monitoring for the development of severe disease is recommended in patients with high deformity scores.
- 27 June 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (13) , 3703
Open AccessA Genotype-Phenotype Study of Multiple Hereditary Exostoses in Forty-Three Patients
Multiple hereditary exostoses (MHE) is a rare autosomal dominant skeletal disorder with a variety of clinical manifestations. We aimed to evaluate the general clinical phenotypic severity of MHE using our own scoring system and analyzed the risk factors associated with severe clinical phenotypes. In this study, 43 patients from 30 families were analyzed. The mutations were identified by direct sequencing of polymerase chain reaction-amplified genomic DNA or by multiplex ligation-dependent probe amplification. According to a new scoring system devised by the authors, the severity of the phenotype was assessed as mild, moderate, or severe based on the deformity of each segment, number of exostoses, leg length discrepancy, and functional limitations. Of 43 patients from 30 families, 39 patients (90.7%) and 24 families (80%) presented with EXT1 or EXT2 mutations. Patients with EXT1 mutations had a significantly worse phenotype than that of patients with EXT2 mutations or without any detectable mutation. The mean clinical score of patients with an EXT1 mutation (5.76; range, 2.0–8.0; SD = 1.60) was higher than that of patients with an EXT2 mutation (4.06; range, 2.0–7.0; SD = 1.47) or of those without any detectable mutation (4.63; range, 3.0–6.0; SD = 1.44; p = 0.005). According to our classification system, more patients with EXT1 mutations had ‘severe disease’ than those with EXT2 mutations. Deformity scores were also higher in patients with EXT1 mutations (p = 0.018). In the multivariate analysis, the deformity score was found to be associated with the ‘severe’ class (p = 0.031). In conclusion, 90.7% of patients with MHE showed EXT mutations. Our scoring system showed reliable results. We suggest that the extent of deformity is an important factor in determining the phenotype of MHE and close monitoring for the development of severe disease is recommended in patients with high deformity scores.
- Open Access
- 8 February 2020
- Published by MDPI AG in Mathematics
- Vol. 8 (2) , 217
Robust Linear Trend Test for Low-Coverage Next-Generation Sequence Data Controlling for Covariates
Low-coverage next-generation sequencing experiments assisted by statistical methods are popular in a genetic association study. Next-generation sequencing experiments produce genotype data that include allele read counts and read depths. For low sequencing depths, the genotypes tend to be highly uncertain; therefore, the uncertain genotypes are usually removed or imputed before performing a statistical analysis. It may result in the inflated type I error rate and in a loss of statistical power. In this paper, we propose a mixture-based penalized score association test adjusting for non-genetic covariates. The proposed score test statistic is based on a sandwich variance estimator so that it is robust under the model misspecification between the covariates and the latent genotypes. The proposed method takes advantage of not requiring either external imputation or elimination of uncertain genotypes. The results of our simulation study show that the type I error rates are well controlled and the proposed association test have reasonable statistical power. As an illustration, we apply our statistic to pharmacogenomics data for drug responsiveness among 400 epilepsy patients.
- 8 February 2020
- Published by MDPI AG in Mathematics
- Vol. 8 (2) , 217
Open AccessRobust Linear Trend Test for Low-Coverage Next-Generation Sequence Data Controlling for Covariates
Low-coverage next-generation sequencing experiments assisted by statistical methods are popular in a genetic association study. Next-generation sequencing experiments produce genotype data that include allele read counts and read depths. For low sequencing depths, the genotypes tend to be highly uncertain; therefore, the uncertain genotypes are usually removed or imputed before performing a statistical analysis. It may result in the inflated type I error rate and in a loss of statistical power. In this paper, we propose a mixture-based penalized score association test adjusting for non-genetic covariates. The proposed score test statistic is based on a sandwich variance estimator so that it is robust under the model misspecification between the covariates and the latent genotypes. The proposed method takes advantage of not requiring either external imputation or elimination of uncertain genotypes. The results of our simulation study show that the type I error rates are well controlled and the proposed association test have reasonable statistical power. As an illustration, we apply our statistic to pharmacogenomics data for drug responsiveness among 400 epilepsy patients.
- 23 January 2020
- Published by Springer Nature in Translational Stroke Research
- Vol. 11 (5) , 1041-1051
ACOX3 Dysfunction as a Potential Cause of Recurrent Spontaneous Vasospasm of Internal Carotid Artery
Recurrent spontaneous vasospasm of the extracranial internal carotid artery (RSV-eICA) is a rarely recognized cause of ischemic stroke in young adults. However, its pathophysiology remains largely unknown. Through whole-exome sequencing of the ACOX3 gene of two dizygotic Korean twin brothers affected by RSV-eICA, we identified two compound heterozygous missense variants c.235 T > G (p.F79 V) and c.665G > A (p.G222E). In silico analysis indicated that both variants were classified as pathogenic. In vitro ACOX3 enzyme assay indicated practically no enzyme activity in both F79 V and G222E mutants. To determine the effect of the mutants on vasospasm, we used a collagen contraction assay on human aortic smooth muscle cells (HASMC). Carbachol, a cholinergic agonist, induces contraction of HASMC. Knockdown of ACOX3 in HASMC, using siRNA, significantly repressed HASMC contraction triggered by carbachol. The carbachol-induced HASMC contraction was restored by transfection with plasmids encoding siRNA-resistant wild-type ACOX3, but not by transfection with ACOX3 G222E or by co-transfection with ACOX3 F79 V and ACOX3 G222E, indicating that the two ACOX3 mutants suppress carbachol-induced HASMC contraction. We propose that an ACOX3 dysfunction elicits a prolonged loss of the basal aortic myogenic tone. As a result, smooth muscles of the ICA’s intermediate segment, in which the sympathetic innervation is especially rich, becomes hypersensitive to sympathomimetic stimuli (e.g., heavy exercise) leading to a recurrent vasospasm. Therefore, ACOX3 dysfunction would be a causal mechanism of RSV-eICA. For the first time, we report the possible involvement of ACOX3 in maintaining the basal myogenic tone of human arterial smooth muscle.
- 23 January 2020
- Published by Springer Nature in Translational Stroke Research
- Vol. 11 (5) , 1041-1051
ACOX3 Dysfunction as a Potential Cause of Recurrent Spontaneous Vasospasm of Internal Carotid Artery
Recurrent spontaneous vasospasm of the extracranial internal carotid artery (RSV-eICA) is a rarely recognized cause of ischemic stroke in young adults. However, its pathophysiology remains largely unknown. Through whole-exome sequencing of the ACOX3 gene of two dizygotic Korean twin brothers affected by RSV-eICA, we identified two compound heterozygous missense variants c.235 T > G (p.F79 V) and c.665G > A (p.G222E). In silico analysis indicated that both variants were classified as pathogenic. In vitro ACOX3 enzyme assay indicated practically no enzyme activity in both F79 V and G222E mutants. To determine the effect of the mutants on vasospasm, we used a collagen contraction assay on human aortic smooth muscle cells (HASMC). Carbachol, a cholinergic agonist, induces contraction of HASMC. Knockdown of ACOX3 in HASMC, using siRNA, significantly repressed HASMC contraction triggered by carbachol. The carbachol-induced HASMC contraction was restored by transfection with plasmids encoding siRNA-resistant wild-type ACOX3, but not by transfection with ACOX3 G222E or by co-transfection with ACOX3 F79 V and ACOX3 G222E, indicating that the two ACOX3 mutants suppress carbachol-induced HASMC contraction. We propose that an ACOX3 dysfunction elicits a prolonged loss of the basal aortic myogenic tone. As a result, smooth muscles of the ICA’s intermediate segment, in which the sympathetic innervation is especially rich, becomes hypersensitive to sympathomimetic stimuli (e.g., heavy exercise) leading to a recurrent vasospasm. Therefore, ACOX3 dysfunction would be a causal mechanism of RSV-eICA. For the first time, we report the possible involvement of ACOX3 in maintaining the basal myogenic tone of human arterial smooth muscle.